National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Eslicarbazepine (Zebinix®) for the treatment of Epilepsy

 Rapid Review

Commenced Completed Outcome
August 2009 01/09/2009 Full Pharmacoeconomic Evaluation Recommended.

 * Company did not submit, Eslicarbazepine (Zebinix®) was reimbursed under the Community Drugs Schemes following introduction of a Patient Access Scheme.